LIV Emles at Home ETF

The Samaritan Foundation and Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today on National DNA day, it is driven to raise money to bring its innovative BioFutureBus, based on the TV show CSI, to kids. The BioFutureBus is a custom make bus that brings a state-of-the-art science laboratory to local schools so kids can experientially learn about the mysteries of science, criminal science and DNA. Similar East Coast BioBus' have demonstrated this form of education as a springboard for an increase in the pursuit of innovation through science and technology degrees. Diana Thompson, Senior Vice President, Public Affairs and Development, stated, "Innovation is our future. In so many ways, scientific innovation is going to influence our lives, the lives of our children, and our standing in the world. We have to do something different to capture the imagination of our children and remain competitive." "National DNA Day is a wonderful opportunity for students to learn from real-life genome researchers how they can join in the effort to use genomics to improve human health," said National Human Genome Research Institute, Director, Francis S. Collins, M.D., Ph.D. To learn more about National DNA day: http://www.genome.gov/10506367 About The Samaritan Innovative Science Foundation The Samaritan Innovative Science Foundation (The Samaritan Foundation) is a 501C(3) nonprofit organization founded in 2003 by Dr. Janet Greeson, CEO, and Eugene Boyle, CFO of Samaritan Pharmaceuticals (AMEX:LIV). The Foundation's focus and passion is to meet the unmet medical and social needs of children. For additional information, visit www.samaritanpharma.org. Samaritan Pharmaceuticals: "We LIV....to Save Lives." Samaritan is a small-cap Biotech, driven to discover, develop and commercialize innovative therapeutics' for AIDS, Alzheimer's, Cancer and Heart disease patients. Look at www.samaritanpharma.com. Please register on Website so we can notify you of upcoming conference calls, news and events.